focus -WSS

focus

author：leisure time 2025-09-30 00:49:11 - browse：267

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： Duchenne breakthrough therapy leaves behind pioneering families

WSS

AI used to predict Covid

Health insurers say they are turning to AI to cut costs, improve care

AI used to predict Covid

Bright Health sells Medicare Advantage business to Molina

Average age of first period drops to 11.9 years, study shows

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

entertainment

focus

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Tori Bowie and the unacceptable rates of Black maternal death

In age of alternative facts, a scholarly course on calling out crap

The cancer drug shortage isn’t new — and neither are the solutions

Novavax promises a turnaround & Lilly roils the obesity market

Average age of first period drops to 11.9 years, study shows

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medical leaders decry Supreme Court decision on affirmative action

How one medical school became remarkably diverse

Hollywood unions extend contract negotiations for actors

focus

Akili, maker of video game for ADHD, to be acquired for 34 million

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Startling documents reveal new facets of Sacklers' opioid empire

After affirmative action ruling, medical educators look to 'holistic review'

Heat waves linked to early deliveries, preterm births in new study

Heat waves linked to early deliveries, preterm births in new study

hotspot

focus

knowledge

leisure time